Legend Biotech Corp (LEGN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $19.28
• Market Cap: $3.64B
• EPS: $-1.28
• 52-Week High: $45.30
• 52-Week Low: $16.24

Market Sentiment

Legend Biotech Corp currently has a Neutral sentiment score of 0.10.

About Legend Biotech Corp

Legend Biotech Corporation is a clinical-stage biopharmaceutical company dedicated to pioneering innovative cell therapies, particularly in oncology, through its proprietary CAR-T cell therapy platform. With a robust pipeline and a commitment to rigorous clinical research, the company is well-positioned to address substantial unmet medical needs and enhance patient outcomes. Strategic collaborations further strengthen its capabilities, making Legend Biotech a compelling prospect for instituti...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Legend Biotech Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LEGN pay dividends?

Legend Biotech Corp (LEGN) does not currently pay a regular dividend.

What is LEGN's market cap?

Legend Biotech Corp (LEGN) has a market capitalization of $3.64B with a current stock price of $19.28.